List view / Grid view
14 June 2016 | By Mandy Parrett, Editorial Assistant
In the face of the enormous costs involved in bringing a drug to market, pharmaceutical companies are increasingly aiming to develop first-in-class treatments to maximise return on this heavy burden, notes intelligence provider, GBI Research.
9 December 2015 | By Victoria White
The gene therapy pipeline has more than 900 products in development, and the early-stage pipeline looks particularly strong with 76% of products at either the discovery or preclinical stage...
2 December 2015 | By Victoria White
GBI Research states that the majority of oncology therapeutics are in the early stages of the pipeline, with 2,937 at the Preclinical stage and 1,591 at the discovery stage...
4 August 2015 | By Victoria White
The oncology drug pipeline is far larger than any other therapy area with 6,484 products in active development across all indications...
